PMID: 9252549

Wilkinson DJ, Strong TV, Mansoura MK, Wood DL, Smith SS, Collins FS, Dawson DC
CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain.
Am J Physiol. 1997 Jul;273(1 Pt 1):L127-33., [PubMed]
Sentences
No. Mutations Sentence Comment
15 ABCC7 p.Ser737Ala
X
ABCC7 p.Ser737Ala 9252549:15:13
status: NEW
view ABCC7 p.Ser737Ala details
In contrast, alanine substitution at serine-737 or -768 actually decreased the KA for activation, suggesting that phosphorylation at either of these sites is inhibitory. Login to comment
64 ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 9252549:64:92
status: NEW
view ABCC7 p.Lys1250Ala details
Interpretation of Dose Response and Rate Analyses In a previous study (20), we used a CFTR (K1250A) mutant that is hypersensitive to activation by IBMX [half-maximal activation constant (&) = 0.07 mM] to obtain evidence that IBMX blocks CFTR channels with a half-maximal inhibition constant (&) of -9.5 mM. Login to comment
85 ABCC7 p.Ser660Ala
X
ABCC7 p.Ser660Ala 9252549:85:195
status: NEW
view ABCC7 p.Ser660Ala details
ABCC7 p.Ser670Ala
X
ABCC7 p.Ser670Ala 9252549:85:224
status: NEW
view ABCC7 p.Ser670Ala details
Activation constants for wild-type and single serine-to-alanine mutant CFTRs PICA Phosphorylation CFTR K4, n-m n Class In vivo In vitro Wild type 0.65 t 0.08 26 S64lA 0.6520.12 14 N No concensus S660A 1.21+ 0.19* 11 S ++ ++ S670A 0.99t0.12* 12 s ? Login to comment
87 ABCC7 p.Ser737Ala
X
ABCC7 p.Ser737Ala 9252549:87:90
status: NEW
view ABCC7 p.Ser737Ala details
ABCC7 p.Ser795Ala
X
ABCC7 p.Ser795Ala 9252549:87:152
status: NEW
view ABCC7 p.Ser795Ala details
ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:87:184
status: NEW
view ABCC7 p.Ser813Ala details
ABCC7 p.Ser686Ala
X
ABCC7 p.Ser686Ala 9252549:87:0
status: NEW
view ABCC7 p.Ser686Ala details
ABCC7 p.Ser768Ala
X
ABCC7 p.Ser768Ala 9252549:87:121
status: NEW
view ABCC7 p.Ser768Ala details
ABCC7 p.Ser712Ala
X
ABCC7 p.Ser712Ala 9252549:87:63
status: NEW
view ABCC7 p.Ser712Ala details
ABCC7 p.Ser700Ala
X
ABCC7 p.Ser700Ala 9252549:87:32
status: NEW
view ABCC7 p.Ser700Ala details
S686A 0.75 ?I 0.07 9 N PKC site S700A 0.86 t 0.07* 12 S ++ +++ S712A 0.67 t 0.12 9 N - ++ S737A 0.35 5 0.05* 8 I +++ +++ S768A 0.09 IT 0.03* 8 I - ++++ S795A 1.24 + 0.22* 9 S +++ ++++ S813A 3.18-+0.36* 6 S ++++ ++ Values of half-maximal inhibition constant for activation (KA) are means + SE by 3-isobutyl-1-methylxanthine (IBMX) obtained for wild-type cystic fibrosis transmembrane conductance regulator (CFTR) and variants with single serine-to-alanine substitutions. Login to comment
107 ABCC7 p.Ser660Ala
X
ABCC7 p.Ser660Ala 9252549:107:116
status: NEW
view ABCC7 p.Ser660Ala details
ABCC7 p.Ser737Ala
X
ABCC7 p.Ser737Ala 9252549:107:123
status: NEW
view ABCC7 p.Ser737Ala details
ABCC7 p.Ser795Ala
X
ABCC7 p.Ser795Ala 9252549:107:137
status: NEW
view ABCC7 p.Ser795Ala details
ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:107:148
status: NEW
view ABCC7 p.Ser813Ala details
ABCC7 p.Ser768Ala
X
ABCC7 p.Ser768Ala 9252549:107:130
status: NEW
view ABCC7 p.Ser768Ala details
Symbols show averaged IBMX dose-response data for wild-type CFTR and several single-site serine-to-alanine mutants (S660A, S737A, S768A, S795A, and S813A). Login to comment
119 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:119:24
status: NEW
view ABCC7 p.Ser813Ala details
100 i - wild type m m - S813A 0 S768,813A A S737,795,813A v S660,795,813A S660,737,795, E Fig. 2. Login to comment
125 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:125:80
status: NEW
view ABCC7 p.Ser813Ala details
For reference, the activation profiles of wild-type CFTR and single-site mutant S813A are shown by the thick continuous and dashed curves, respectively. Login to comment
129 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:129:220
status: NEW
view ABCC7 p.Ser813Ala details
One triple mutant (S737, 795, 813A) eliminated one inhibitory site (S737) and two stimulatory sites (S795 and S813), and the sensitivity to activation was not significantly different from that of the single-site mutant, S813A, as if the effects of eliminating S737 and S795 roughly canceled. Login to comment
130 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:130:167
status: NEW
view ABCC7 p.Ser813Ala details
In contrast, the other triple mutant (S660, 795, 813A), which lacked the three strongest stimulatory sites, exhibited a KA that was substantially greater than that of S813A, indicating that the effects produced by eliminating each of these sites summed such that the activation sensitivity of CFTR was considerably impaired. Login to comment
132 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:132:153
status: NEW
view ABCC7 p.Ser813Ala details
The value of KA was significantly reduced compared with that observed with the triple mutant (S660, 795,813A) but was significantly greater than that of S813A, again indicating a summation of effects such that the elimination of S737 partially ameliorated the reduced activation sensitivity produced by eliminating S660 and S795. Login to comment
135 ABCC7 p.Ser768Ala
X
ABCC7 p.Ser768Ala 9252549:135:72
status: NEW
view ABCC7 p.Ser768Ala details
CFTR 1O-3 min-l n min 1O-3 mix1 n Wild type 664+51 20 6.0 + 0.3 8826 16 S768A 1,055 5 66* 9 12.7 5 1.7* 112? Login to comment
136 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:136:5
status: NEW
view ABCC7 p.Ser813Ala details
26 7 S813A 533t75* 8 2.7 + 0.3* 173515* 9 Summary of activation and deactivation parameters (means 5 SE) for wild-type CFTR and the alanine substitution mutants of the strongest inhibitory (S768) and stimulatory (S813) phosphorylation sites. Login to comment
145 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:145:124
status: NEW
view ABCC7 p.Ser813Ala details
The data displayed in Table 3 indicate that the rate of approach to the activated steady state was decreased by -20% in the S813A construct, whereas the deactivation parameters, the latency, and the subsequent rate of exponential decline (*&E) indicated a destabilization of the active state. Login to comment
148 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:148:147
status: NEW
view ABCC7 p.Ser813Ala details
Deactivation parameters were consistent with stabilization of the active state; the latency was double that of wild-type CFTR, Y 80 zl 2 60 0 wt 0 S813A B 5 minutes z 80 iii n 60 0 10 20 30 40 50 minutes Fig. 3. Login to comment
149 ABCC7 p.Ser813Ala
X
ABCC7 p.Ser813Ala 9252549:149:129
status: NEW
view ABCC7 p.Ser813Ala details
ABCC7 p.Ser768Ala
X
ABCC7 p.Ser768Ala 9252549:149:119
status: NEW
view ABCC7 p.Ser768Ala details
Representative time courses for the activation (A) and deactivation (B) of wild-type (wt) CFTR and single-site mutants S768A and S813A after, respectively, exposure to 10 PM forskolin and 5 mM IBMX and the removal of these drugs from the perfusate. Login to comment
174 ABCC7 p.Ser768Ala
X
ABCC7 p.Ser768Ala 9252549:174:36
status: NEW
view ABCC7 p.Ser768Ala details
It is particularly interesting that S768A, the most important inhibitory site, according to the dose-response assay, has not been clearly identified as an in vivo site. Login to comment
189 ABCC7 p.Ser660Ala
X
ABCC7 p.Ser660Ala 9252549:189:103
status: NEW
view ABCC7 p.Ser660Ala details
Gadsby and Nairn (10) called attention to the fact that the open probability of constructs like CFTRAR-S660A is well below that of wild-type channels. Login to comment